-+ 0.00%
-+ 0.00%
-+ 0.00%

B. Riley Securities Maintains Buy on OptimizeRx, Raises Price Target to $11

Benzinga·09/29/2026 15:42:14
语音播报
B. Riley Securities analyst Anderson Schock maintains OptimizeRx (NASDAQ:OPRX) with a Buy and raises the price target from $10 to $11.